Literature DB >> 16036402

The incidence of severe complications of preeclampsia.

Sohinee Bhattacharya1, Doris M Campbell.   

Abstract

OBJECTIVES: To examine the incidence of life-threatening (near-miss) complications, including hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome occurring in women with preeclampsia in the Grampian region of Scotland between 1981 and 2000. SUBJECTS AND METHODS: All women who were resident in a geographically determined region (the Grampian region of Scotland) and who developed moderate to severe preeclampsia in the time period 1981 to 2000 were identified from the Aberdeen Maternity and Neonatal Databank. All complications occurring antepartum, intrapartum, or postpartum in these pregnancies were listed as International Classification of Diseases (ICD) codes and significant complications were identified from these. The cases of HELLP syndrome were identified by case note review. Data were analyzed using Statistical Package for Social Scientists (SPSS).
RESULTS: A total of 4188 cases of preeclampsia were identified over the 20-year period. Six percent (approx. 1 in 16) of preeclamptics developed one or more major systemic complications. The incidence of placental abruption and eclampsia was 2.8% and 1.65%, respectively. Hematological complications were most common, with reduced platelets accounting for about half of these cases; although, a definite diagnosis of HELLP syndrome could only be made in 13 cases over 20 years. After adjusting for gestational age, a woman was 1.14 times more likely to have a caesarean delivery (95% C.I. 1.08, 1.20) if she had complicated preeclampsia. She was also more likely to have a stillbirth [Odds Ratio (O.R.) = 1.45 (95% C.I. (confidence interval) 1.02, 2.29)] or a neonatal death [O.R. = 2.25 (95% C.I. 1.12, 4.260].
CONCLUSIONS: There has been a gradual decline in the rate of preeclampsia in the Grampian region of Scotland over the time period 1986 to 2000; although, the percentage of pre-eclamptics who developed one or more complications has not decreased appreciably. In fact, the incidence of eclampsia and placental abruption has increased in the most recent five years. The presence of complications in preeclampsia is associated with a poor neonatal outcome.

Entities:  

Mesh:

Year:  2005        PMID: 16036402     DOI: 10.1081/PRG-200059873

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  7 in total

1.  Uric acid: is it time to give up routine testing in management of pre-eclampsia?

Authors:  Vikram Sinai Talaulikar; Hassan Shehata
Journal:  Obstet Med       Date:  2012-03-29

2.  First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

Authors:  Roberto Romero; Juan Pedro Kusanovic; Nandor Gabor Than; Offer Erez; Francesca Gotsch; Jimmy Espinoza; Samuel Edwin; Ilana Chefetz; Ricardo Gomez; Jyh Kae Nien; Marei Sammar; Beth Pineles; Sonia S Hassan; Hamutal Meiri; Yossi Tal; Ido Kuhnreich; Zoltan Papp; Howard S Cuckle
Journal:  Am J Obstet Gynecol       Date:  2008-06-09       Impact factor: 8.661

3.  Maternal sepsis: a Scottish population-based case-control study.

Authors:  C D Acosta; S Bhattacharya; D Tuffnell; J J Kurinczuk; M Knight
Journal:  BJOG       Date:  2012-01-18       Impact factor: 6.531

4.  Semiautonomous Treatment Algorithm for the Management of Severe Hypertension in Pregnancy.

Authors:  Courtney Martin; James Pappas; Kim Johns; Heather Figueroa; Kevin Balli; Ruofan Yao
Journal:  Obstet Gynecol       Date:  2021-02-01       Impact factor: 7.661

Review 5.  Reviewing Accuracy of First Trimester Screening for Preeclampsia Using Maternal Factors and Biomarkers.

Authors:  Sarah L Malone; Rani Haj Yahya; Stefan C Kane
Journal:  Int J Womens Health       Date:  2022-09-19

6.  Maternofoetal complications and their association with proteinuria in a tertiary care hospital of a developing country.

Authors:  Archana Kumari; Avinash Chakrawarty; Abha Singh; Ritu Singh
Journal:  J Pregnancy       Date:  2014-04-14

7.  Clinical characteristics and pregnancy outcomes of atypical hemolysis, elevated liver enzymes, and low platelets syndrome: A case series.

Authors:  Ruoan Jiang; Ting Wang; Baohua Li; Jing He
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.